1 – 10 of 10
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Acromegaly management in the Nordic countries: A Delphi consensus survey
(
- Contribution to journal › Article
- 2022
-
Mark
Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis : analysis of the KIMS database
(
- Contribution to journal › Article
- 2021
-
Mark
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
(
- Contribution to journal › Article
- 2019
-
Mark
Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy
(
- Contribution to journal › Article
-
Mark
Cerebral infarction after fractionated stereotactic radiation therapy of benign anterior skull base tumors
(
- Contribution to journal › Article
- 2018
-
Mark
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial
(
- Contribution to journal › Article
- 2017
-
Mark
Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults : findings in a prospective cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues - Observations in two patients with acromegaly and severe headache.
(
- Contribution to journal › Article
-
Mark
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
(
- Contribution to journal › Article
- 2014
-
Mark
Giant prolactinomas in women
(
- Contribution to journal › Article